{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:17:18Z","timestamp":1791919038789,"version":"4.3.4"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives of Oral Biology"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.archoralbio.2018.04.015","type":"journal-article","created":{"date-parts":[[2018,4,30]],"date-time":"2018-04-30T18:34:48Z","timestamp":1525113288000},"page":"32-37","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":109,"special_numbering":"C","title":["Curcumin enhances anti-tumor immune response in tongue squamous cell carcinoma"],"prefix":"10.1016","volume":"92","author":[{"given":"Feng","family":"Liao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"En","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.archoralbio.2018.04.015_bib0005","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/jop.12455","article-title":"In vivo and in vitro effects of curcumin on head and neck carcinoma: A systematic review","volume":"46","author":"Borges","year":"2017","journal-title":"Journal of Oral Pathology and Medicine"},{"key":"10.1016\/j.archoralbio.2018.04.015_bib0010","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1177\/0022034517712435","article-title":"STAT3 induces immunosuppression by upregulating PD-1\/PD-L1 in HNSCC","volume":"96","author":"Bu","year":"2017","journal-title":"Journal of Dental Research"},{"key":"10.1016\/j.archoralbio.2018.04.015_bib0015","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1093\/annonc\/mdv615","article-title":"Regulation of PD-L1: A novel role of pro-survival signalling in cancer","volume":"27","author":"Chen","year":"2016","journal-title":"Annals of Oncology"},{"key":"10.1016\/j.archoralbio.2018.04.015_bib0020","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1002\/hed.24595","article-title":"Inflammation-induced myeloid-derived suppressor cells associated with squamous cell carcinoma of the head and neck","volume":"39","author":"Chen","year":"2017","journal-title":"Head and Neck"},{"key":"10.1016\/j.archoralbio.2018.04.015_bib0025","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/j.1601-0825.2011.01846.x","article-title":"Myeloid-derived suppressor cells contribute to oral cancer progression in 4NQO-treated mice","volume":"18","author":"Chu","year":"2012","journal-title":"Oral Diseases"},{"key":"10.1016\/j.archoralbio.2018.04.015_bib0030","doi-asserted-by":"crossref","first-page":"51024","DOI":"10.18632\/oncotarget.16882","article-title":"Relevance of CCL3\/CCR5 axis in oral carcinogenesis","volume":"68","author":"da Silva","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.archoralbio.2018.04.015_bib0035","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1093\/annonc\/mdw226","article-title":"The promise of immunotherapy in head and neck squamous cell carcinoma","volume":"27","author":"Economopoulou","year":"2016","journal-title":"Annals of Oncology"},{"key":"10.1016\/j.archoralbio.2018.04.015_bib0040","doi-asserted-by":"crossref","first-page":"e1226719","DOI":"10.1080\/2162402X.2016.1226719","article-title":"CD24 blunts oral squamous cancer development and dampens the functional expansion of myeloid-derived suppressor cells","volume":"5","author":"Fugle","year":"2016","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.archoralbio.2018.04.015_bib0045","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/mt.2015.10","article-title":"The clinical relevance of the miR-197\/CKS1B\/STAT3-mediated PD-L1 network in chemoresistant non-small-cell lung cancer","volume":"23","author":"Fujita","year":"2015","journal-title":"Molecular Therapy"},{"key":"10.1016\/j.archoralbio.2018.04.015_bib0050","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/nri3175","article-title":"Coordinated regulation of myeloid cells by tumours","volume":"12","author":"Gabrilovich","year":"2012","journal-title":"Nature Reviews. Immunology"},{"key":"10.1016\/j.archoralbio.2018.04.015_bib0055","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1016\/j.joms.2017.01.006","article-title":"Clinical course of oral squamous cell carcinoma in patients on immunosuppressant and glucocorticoid therapy","volume":"75","author":"Hirai","year":"2017","journal-title":"Journal of Oral and Maxillofacial Surgery"},{"key":"10.1016\/j.archoralbio.2018.04.015_bib0060","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.4049\/jimmunol.1203195","article-title":"Transmembrane TNF-alpha promotes suppressive activities of myeloid-derived suppressor cells via TNFR2","volume":"192","author":"Hu","year":"2014","journal-title":"The Journal of Immunology"},{"key":"10.1016\/j.archoralbio.2018.04.015_bib0065","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1093\/carcin\/22.4.567","article-title":"Xeroderma pigmentosum group A gene action as a protection factor against 4-nitroquinoline 1-oxide-induced tongue carcinogenesis","volume":"22","author":"Ide","year":"2001","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.archoralbio.2018.04.015_bib0070","first-page":"69","article-title":"Global cancer statistics","volume":"61","author":"Jemal","year":"2011","journal-title":"CA: A Cancer Journal for Clinicians"},{"key":"10.1016\/j.archoralbio.2018.04.015_bib0075","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/nrclinonc.2018.8","article-title":"Targeting the IL-6\/JAK\/STAT3 signalling axis in cancer","volume":"15","author":"Johnson","year":"2018","journal-title":"Nature Reviews Clinical Oncology"},{"key":"10.1016\/j.archoralbio.2018.04.015_bib0080","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1042\/CS20160935","article-title":"Curcumin mediates anticancer effects by modulating multiple cell signaling pathways","volume":"131","author":"Kunnumakkara","year":"2017","journal-title":"Clinical Science (London)"},{"key":"10.1016\/j.archoralbio.2018.04.015_bib0085","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1172\/JCI96113","article-title":"Host expression of PD-L1 determines efficacy of PD-L1 pathway blockade-mediated tumor regression","volume":"128","author":"Lin","year":"2018","journal-title":"The Journal of Clinical Investigation"},{"key":"10.1016\/j.archoralbio.2018.04.015_bib0090","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s00432-009-0634-0","article-title":"Population alterations of L-arginase- and inducible nitric oxide synthase-expressed CD11b+\/CD14(\u2212)\/CD15+\/CD33+ myeloid-derived suppressor cells and CD8+ T lymphocytes in patients with advanced-stage non-small cell lung cancer","volume":"136","author":"Liu","year":"2010","journal-title":"Journal of Cancer Research and Clinical Oncology"},{"key":"10.1016\/j.archoralbio.2018.04.015_bib0095","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.critrevonc.2017.06.001","article-title":"Biomarkers of response to PD-1\/PD-L1 inhibition","volume":"116","author":"Maleki Vareki","year":"2017","journal-title":"Critical Reviews in Oncology\/Hematology"},{"key":"10.1016\/j.archoralbio.2018.04.015_bib0100","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1080\/08820139.2016.1194428","article-title":"Role of tregs in cancer dormancy or recurrence","volume":"45","author":"Manjili","year":"2016","journal-title":"Immunological Investigations"},{"key":"10.1016\/j.archoralbio.2018.04.015_bib0105","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.oraloncology.2016.12.010","article-title":"Preclinical models in HNSCC: A comprehensive review","volume":"65","author":"Mery","year":"2017","journal-title":"Oral Oncology"},{"key":"10.1016\/j.archoralbio.2018.04.015_bib0110","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.wjorl.2016.05.007","article-title":"Intra-tumor heterogeneity in head and neck cancer and its clinical implications","volume":"2","author":"Mroz","year":"2016","journal-title":"World Journal of Otorhinolaryngol Head Neck Surg"},{"key":"10.1016\/j.archoralbio.2018.04.015_bib0115","doi-asserted-by":"crossref","first-page":"52889","DOI":"10.18632\/oncotarget.17547","article-title":"PD-L1: A novel prognostic biomarker in head and neck squamous cell carcinoma","volume":"28","author":"Muller","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.archoralbio.2018.04.015_bib0120","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.oraloncology.2008.05.023","article-title":"Oral cancer prevention and control-the approach of the World Health Organization","volume":"45","author":"Petersen","year":"2009","journal-title":"Oral Oncology"},{"key":"10.1016\/j.archoralbio.2018.04.015_bib0125","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s00251-017-1015-5","article-title":"PD-1 and cancer: mPD-1 and cancer: Molecular mechanisms and polymorphisms","volume":"70","author":"Salmaninejad","year":"2017","journal-title":"Immunogenetics"},{"key":"10.1016\/j.archoralbio.2018.04.015_bib0130","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1002\/ardp.200900319","article-title":"Curcumin in cancer chemoprevention: Molecular targets, pharmacokinetics, bioavailability, and clinical trials","volume":"343","author":"Shehzad","year":"2010","journal-title":"Archiv der Pharmazie"},{"key":"10.1016\/j.archoralbio.2018.04.015_bib0135","article-title":"Immunohistochemical analysis of Foxp3+, CD4+, CD8+ cell infiltrates and PD-L1 in oral squamous cell carcinoma","volume":"1","author":"Stasikowska-Kanicka","year":"2017","journal-title":"Pathology Oncology Research"},{"key":"10.1016\/j.archoralbio.2018.04.015_bib0140","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.tvjl.2015.11.006","article-title":"Animal models of head and neck squamous cell carcinoma","volume":"210","author":"Supsavhad","year":"2016","journal-title":"Veterinary Journal"},{"key":"10.1016\/j.archoralbio.2018.04.015_bib0145","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1158\/1078-0432.CCR-14-1711","article-title":"Tadalafil reduces myeloid-derived suppressor cells and regulatory T cells and promotes tumor immunity in patients with head and neck squamous cell carcinoma","volume":"21","author":"Weed","year":"2015","journal-title":"Clinical Cancer Research"},{"key":"10.1016\/j.archoralbio.2018.04.015_bib0150","doi-asserted-by":"crossref","first-page":"5821","DOI":"10.4049\/jimmunol.1400404","article-title":"Regulatory T cells and myeloid-derived suppressor cells in the tumor microenvironment undergo Fas-dependent cell death during IL-2\/alphaCD40 therapy","volume":"192","author":"Weiss","year":"2014","journal-title":"The Journal of Immunology"},{"key":"10.1016\/j.archoralbio.2018.04.015_bib0155","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.oraloncology.2014.04.003","article-title":"The role of the PD-L1:PD-1 pathway in squamous cell carcinoma of the head and neck","volume":"50","author":"Zandberg","year":"2014","journal-title":"Oral Oncology"},{"key":"10.1016\/j.archoralbio.2018.04.015_bib0160","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1007\/s00784-013-1146-5","article-title":"Increased frequency of CD4+ CD25+ FOXP3+ cells correlates with the progression of 4-nitroquinoline1-oxide-induced rat tongue carcinogenesis","volume":"18","author":"Zhao","year":"2014","journal-title":"Clinical Oral Investigations"}],"container-title":["Archives of Oral Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003996918301365?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003996918301365?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T11:34:58Z","timestamp":1604230498000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003996918301365"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":32,"alternative-id":["S0003996918301365"],"URL":"https:\/\/doi.org\/10.1016\/j.archoralbio.2018.04.015","relation":{},"ISSN":["0003-9969"],"issn-type":[{"value":"0003-9969","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Curcumin enhances anti-tumor immune response in tongue squamous cell carcinoma","name":"articletitle","label":"Article Title"},{"value":"Archives of Oral Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.archoralbio.2018.04.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}